Ascentage Pharma Group International

Research Ascentage Pharma Group International (AAPG) on Bullrun: market cap USD 1.65B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerAAPG
• ExchangeNASDAQ
• CountryChina
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 1.65B
• Financial periodFY2024
• RevenueUSD 980.65M
• Revenue growth341.8%
• Net income-USD 405.43M

Valuation Snapshot

latest market cap is USD 1.65B.

About Ascentage Pharma Group International

Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company's primary product candidate is HQP1351, a BCR-ABL inhibitor targeting BCR-ABL1 mutants, including those with the T315I mutation. It also develops APG-2575, an oral administered Bcl-2 selective inhibitor for hematologic malignancies and solid tumors;

Frequently asked questions

What is Ascentage Pharma Group International's market cap?

Ascentage Pharma Group International's market capitalization is USD 1.65B.

What does Ascentage Pharma Group International do?

Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China.